Does FENOFIBRATE Cause Malignant neoplasm progression? 33 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Malignant neoplasm progression have been filed in association with FENOFIBRATE (Fenofibrate). This represents 0.6% of all adverse event reports for FENOFIBRATE.
33
Reports of Malignant neoplasm progression with FENOFIBRATE
0.6%
of all FENOFIBRATE reports
10
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From FENOFIBRATE?
Of the 33 reports, 10 (30.3%) resulted in death, 1 (3.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FENOFIBRATE. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does FENOFIBRATE Cause?
Myalgia (411)
Dyspnoea (373)
Fatigue (365)
Asthenia (356)
Dizziness (356)
Fall (354)
Drug ineffective (326)
Pruritus (325)
Nausea (311)
Diarrhoea (310)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which FENOFIBRATE Alternatives Have Lower Malignant neoplasm progression Risk?
FENOFIBRATE vs FENOFIBRIC ACID
FENOFIBRATE vs FENOTEROL
FENOFIBRATE vs FENOTEROL HYDROBROMIDE
FENOFIBRATE vs FENOTEROL HYDROBROMIDE\IPRATROPIUM
FENOFIBRATE vs FENTANYL